FCF Yield
Higher than 50% of Healthcare sector peers
Updated 79h ago
Sector Performance
50th percentileCAH
3.4%
Sector Median
3.4%
Sector Avg
-13.0%
Deep Analysis
Cardinal Health's current FCF Yield of 3.4% means the company generates $3.40 in free cash flow for every $100 of its stock price — a measure of how much cash profit the business throws off relative to its market value.
This yield exactly matches the Healthcare sector median of 3.4%, placing the stock at the 48th percentile among sector peers, essentially right in the middle. Year-over-year change is not available, but quarter-over-quarter FCF Yield declined by 5.6%, from 3.6% to 3.4%. The combination of a sector-median level with a modest quarterly drop suggests no acute risk but also no immediate opportunity for cash-driven returns to improve. This narrow trend aligns with the overall NEUTRAL verdict — the metric does not signal either a compelling bargain or a reason to avoid the stock.
Frequently Asked Questions
What does the FCF Yield tell investors about CAH?
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
How is the FCF Yield calculated?
FCF Yield is calculated as: Free Cash Flow / Market Cap.
How does CAH's FCF Yield compare to its sector?
CAH's FCF Yield of 3.4% compares to a Healthcare sector median of 3.4%, placing it in the 50th percentile.
Who are CAH's closest peers by FCF Yield?
The closest Healthcare peers by FCF Yield include: ABT (3.4%), AZN (3.0%), BAX (2.9%), A (2.8%), RVTY (4.1%).
The Formula
Free Cash Flow / Market Cap
Why It Matters
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Master CAH's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CAH research report →CAH
3.4%
Sector Median
3.4%
Sector Avg
-13.0%
How CAH's FCF Yield compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.